Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
10- 10.15Pre-market26.10.15 19:026-KKey event#●●●
Clinuvel Pharmaceuticals Ltd
Clinuvel Pharmaceuticals filed an Appendix 3H notification regarding the cessation of securities with the Australian Securities Exchange on October 15, 2026. This filing formalizes the cancellation of certain securities, and investors should note the resulting changes to the company's capital structure.…more
$4.98+1.12%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.7Pre-market26.10.07 19:036-KKey event
Clinuvel Pharmaceuticals Ltd
Clinuvel Pharmaceuticals filed documents with the Australian Securities Exchange (ASX) on October 5, 2026, including an application for quotation of securities and a notification of cessation of securities. These filings have been formally reported to the U.S. SEC via Form 6-K.…more
$4.98+1.12%vs prev closeView filingShare - 10.2Regular26.10.03 00:286-KKey event
Clinuvel Pharmaceuticals Ltd
Clinuvel Pharmaceuticals filed its Notice of Annual General Meeting and Proxy Form with the Australian Securities Exchange (ASX) on October 1, 2026. This filing formalizes the procedural requirements for the company's upcoming annual general meeting.…more
$4.98+1.12%vs prev closeView filingShare
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.27Overnight26.08.27 15:21#●●●#●●●
CLINUVEL FY2026 Revenue Dips 1% to $94M, Cash Reserves Rise 12%
CLINUVEL reported a 1% decline in FY2026 revenue to $94.0 million compared to the previous year. Despite the slight revenue dip, the company increased its cash reserves by 12% to $252.1 million, supporting its ongoing U.S. expansion strategy.…more
$4.98+1.12%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 8.27Overnight26.08.27 14:42
●●●●●●●● ●●●●● ●●●●●●
Clinuvel Pharmaceuticals achieved its tenth consecutive year of profitability, maintaining a strong balance sheet despite a marginal decline in annual revenue. The company plans to leverage its significant cash reserves to accelerate its strategic expansion into the U.S. market.…more
$4.98+1.12%vs prev close
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report